Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1896403 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503524 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503187 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3503495 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1065093 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1265010 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL1060504 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3288792 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL247007 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 | |
| SCHEMBL3501621 | 1.00 | CYP1A2 (0.59) | CYP1A2DGKAALDH1A1ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116253640-A | Vegetable oil polyol and preparation method and application thereof | 南京工业大学 | 2023-06-13 | — | — | CN | claimed |
| CN-103232345-B | Synthesis method of 8-hydroxyl ethyl caprylate | JIANGSU BOTAI PHARMACEUTICAL COMPANY LTD | 2015-04-08 | — | — | CN | claimed |
| CN-103232345-A | Synthesis method of 8-hydroxyl ethyl caprylate | JIANGSU BOTAI PHARMACEUTICAL CO LTD | 2013-08-07 | — | — | CN | claimed |
| CN-118255666-A | Preparation method and application of vegetable oil polyol | 广东腐蚀科学与技术创新研究院 | 2024-06-28 | — | — | CN | disclosed |
| WO-2024102970-A1 | COMPOUNDS FOR MODULATING SYK ACTIVITY AND E3 UBIQUITIN LIGASE ACTIVITY | Kronos Bio, Inc. (US) | 2024-05-16 | — | — | WO | disclosed |
| CN-113773182-B | Method for synthesizing 6, 8-dichloro octanoate | 风火轮(上海)生物科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| CN-116253640-A | Vegetable oil polyol and preparation method and application thereof | 南京工业大学 | 2023-06-13 | — | — | CN | disclosed |
| CN-107636158-B | Biocatalytic oxidation | 赢创运营有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113773182-A | Method for synthesizing 6, 8-dichloro caprylic acid ester | 风火轮(上海)生物科技有限公司 | 2021-12-10 | — | — | CN | disclosed |
| US-20210196842-A1 | SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2021-07-01 | — | — | US | disclosed |
| EP-2560987-B1 | BIOCATALYTICAL OXIDATION PROCESS WITH ALKL GENE PRODUCT | EVONIK DEGUSSA GMBH (DE) | 2019-02-20 | — | — | EP | disclosed |
| CN-103232345-A | Synthesis method of 8-hydroxyl ethyl caprylate | JIANGSU BOTAI PHARMACEUTICAL CO LTD | 2013-08-07 | — | — | CN | disclosed |
| EP-2560987-A1 | BIOCATALYTIC OXIDATION PROCESS WITH ALKL GENE PRODUCT | Evonik Degussa GmbH (DE) | 2013-02-27 | — | — | EP | disclosed |
| WO-2011131420-A1 | BIOCATALYTIC OXIDATION PROCESS WITH ALKL GENE PRODUCT | EVONIK DEGUSSA GMBH (DE) | 2011-10-27 | — | — | WO | disclosed |
| US-20100210745-A1 | Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes | REACTIVE SURFACES, LTD. (US) | 2010-08-19 | — | — | US | disclosed |
| US-20020099065-A1 | Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents | GLYCODESIGN INC. (CA) | 2002-07-25 | — | — | US | disclosed |
| EP-0711144-A1 | COSMETIC COMPOSITION CONTAINING ALPHA HYDROXY ACIDS | UNILEVER PLC (GB) | 1996-05-15 | — | — | EP | disclosed |
| EP-0684040-A2 | Skin treatment composition | UNILEVER PLC (GB) | 1995-11-29 | — | — | EP | disclosed |
| US-5451405-A | Cosmetics | CHESEBROUGH-POND'S USA CO. (US) | 1995-09-19 | — | — | US | disclosed |
| WO-1995003032-A1 | COSMETIC COMPOSITION CONTAINING ALPHA HYDROXY ACIDS | UNILEVER PLC (GB) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210196842-A1 | SITE-SPECIFIC RADIOFLUORINATION OF PEPTIDES WITH 8-[18F]-FLUOROOCTANOIC ACID CATALYZED BY LIPOIC ACID LIGASE | DLAT, FABP7, ACSL1 | CYP1A2 3526/4885DGKA 2699/4885ALDH1A1 1130/4885 |
| US-20020099065-A1 | Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents | WDR5, WDR3, WDR77 | CYP1A2 3136/4885DGKA 2809/4885ALDH1A1 4125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.